These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 10493532

  • 41. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW.
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [Abstract] [Full Text] [Related]

  • 42. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T, Kobayashi H, Wakahara K, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    FEBS Lett; 2004 Oct 22; 576(3):408-16. PubMed ID: 15498571
    [Abstract] [Full Text] [Related]

  • 43. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ.
    Cell Growth Differ; 2001 Jan 22; 12(1):9-18. PubMed ID: 11205746
    [Abstract] [Full Text] [Related]

  • 44. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A.
    Biochem J; 2002 Dec 15; 368(Pt 3):683-93. PubMed ID: 12223100
    [Abstract] [Full Text] [Related]

  • 45. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
    Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M.
    Surgery; 2004 Aug 15; 136(2):364-74. PubMed ID: 15300203
    [Abstract] [Full Text] [Related]

  • 46. Down-regulation of transforming growth factor-beta receptors: cooperativity between the types I, II, and III receptors and modulation at the cell surface.
    Zwaagstra JC, Kassam Z, O'Connor-Mccourt MD.
    Exp Cell Res; 1999 Nov 01; 252(2):352-62. PubMed ID: 10527625
    [Abstract] [Full Text] [Related]

  • 47. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F, Strand DW, Rowley DR.
    Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743
    [Abstract] [Full Text] [Related]

  • 48. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ.
    Oncogene; 1999 Apr 01; 18(13):2213-9. PubMed ID: 10327067
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 01; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 52. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 53. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D, Tang XM, Ma C, Chegini N.
    Gynecol Oncol; 2001 May 01; 81(2):301-9. PubMed ID: 11330966
    [Abstract] [Full Text] [Related]

  • 54. Altered expression of the receptor and ligand in the TGF beta signaling pathway in diffusely infiltrating colon carcinoma.
    Nagayama S, Onodera H, Toguchida J, Imamura M.
    Anticancer Res; 2002 May 01; 22(6B):3545-54. PubMed ID: 12552954
    [Abstract] [Full Text] [Related]

  • 55. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM.
    Cancer Res; 2003 Aug 01; 63(15):4731-8. PubMed ID: 12907656
    [Abstract] [Full Text] [Related]

  • 56. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.